Bipolar depression: L-thyroxine augmentation as a possibility of drug treatment;Bipolare depression: L-thyroxin-augmentation als möglichkeit einer medikamentösen behandlung

PsychoNeuro

Volumn 29, Issue 9, 2003, Pages 400-402

  Sasse, Johanna ^b   Köberle, Ursula ^b   Bschor, Tom ^b   Adli, Mazda ^b   Trendelenburg, Monika ^b   Bauer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Bipolar mood disorder; Depression; Levothyroxine; Thyroid hormones

Indexed keywords

LEVOTHYROXINE; PLACEBO; THYROID HORMONE;

BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; MOOD DISORDER; MULTICENTER STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; TERATOGENESIS; TREATMENT INDICATION;

EID: 0141892134     PISSN: 16119991     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43142     Document Type: Short Survey

References (18)

1. Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry 2001; 158: 1617-1622
2. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression. Arch Gen Psychiatry 1996; 53: 842-848
3. Bauer M, Adli M, Bschor T, Heinz A, Rasgon N, Frye M, Grunze H, Kupka R, Whybrow PC. Clinical applications of levothyroxine in refractory mood disorders. Clin Appr Bipol Disord 2003; 2: 49-56
4. Bauer M, Baur H, Berghöfer A, Ströhle A, Hellweg R, Müller-Oerlinghausen B et al. Effects of supraphysiological thyroxine adminstration in healthy controls and patients with depressive disorders. J Affect Disord 2002; 68: 285-294
5. Bauer M, Berghöfer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R, Adli M, Baethge C, Müller-Oerlinghausen B. Supraphyslological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology 2002; 27: 620-628
6. Bauer M, Hellweg R, Gräf KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998; 18: 444-455
7. Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler L, Mandelkern MA, Bramen J, Woods R, Mazziotta JC, Whybrow PC. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in women with bipolar disorder. Eingereichtes Manuskript
8. Bauer M, Szuba MP, Whybrow PC. Psychiatric and behavioral manifestations of hyperthyroidism and hypothyroidism. In: Wolkowitz OM, Rothschild AJ, eds. Psychoneuroendocrinology. The Scientific Basis of Clinical Practice. American Psychiatric Press, Inc., Washington D.C. 2003: 419-444
9. Bauer M, Whybrow PC. Thyroid hormone, brain and behavior. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (eds). Hormones, brain and behavior. Academic Press, San Diego, 2002; 239-264
10. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study. Arch Gen Psychiatry 1990; 47: 435-440
11. Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder I. Association with grade I hypothyroidism. Arch Gen Psychiatry 1990; 47: 427-432
12. Baumgartner A. Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. International Journal of Neuropsychopharmacology 2000; 3: 149-165
13. Bschor T, Bauer M; Schilddrüsenhormone in der Behandlung affektiver Störungen. Psychopharmakotherapie 1998; 5: 94-98
14. Extein I, Pottash ALC, Gold MS. Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? J Clin Psychiatry 1982; 43: 290-291
15. Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research 1990; 32: 241-251
16. Stancer HC, Persad E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 1982; 39: 311-312
17. Sullivan GM, Hatterer JA, Herbert J, Chen X, Roose SP, Attia E et al. Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry 1999; 156: 710-715
18. Whybrow PC, Bauer M. Behavioral and psychiatric aspects of thyrotoxicosis. In: Braverman LE, Utlger RD (eds). The Thyroid. A Fundamental an Clinical Text (8th edition). Lippincott-Raven, Philadelphia, 2000: 673-678